Each year in the United States, more people are enrolled in health insurance policies that require them to pay a high amount out of pocket before the policy starts paying for care. We know that having a high-deductible policy results in people delaying or skipping care for acute medical conditions. Less is known about the effect of highdeductible insurance policies on care for rare but serious chronic complications of diseases, such as diabetes Why did the researchers do this particular study? To determine whether a transition from low-deductible insurance to high-deductible insurance is associated with delayed medical care for macrovascular complications of diabetes.
Why did the researchers do this particular study?
To determine whether a transition from low-deductible insurance to high-deductible insurance is associated with delayed medical care for macrovascular complications of diabetes.
Who was studied?
The researchers studied several hundred thousand people in the United States with diabetes who got their health insurance through their employer and were enrolled during 2003 to 2012. All of the employers used the same national health insurance company.
How was the study done?
During the study, some employers kept their employees (and the employees' dependents) enrolled in a low-deductible insurance plan that required them to pay up to $500 each year before the policy started paying for care. Other employers provided such a low-deductible plan earlier in the study period but switched during the study to a high-deductible plan that required each enrollee to pay at least $1000 each year before the policy started paying for care. The researchers compared enrollees with diabetes who stayed in a low-deductible plan with those who were switched to a high-deductible plan.
What did the researchers find?
Compared with enrollees with diabetes who stayed in a low-deductible plan, those who were switched to a high-deductible plan waited 1.5 months longer before they sought care for their first major symptom of atherosclerotic blood vessel disease. In addition, these employees had a delay of almost 2 months before getting their first major diagnostic test for atherosclerotic blood vessel disease and a little more than 3 months before having their first procedure-based treatment for atherosclerotic blood vessel disease.
What were the limitations of the study?
This study examined the process of care, but it did not study whether patients had similar health and medical outcomes.
What are the implications of the study?
People with diabetes who are enrolled in high-deductible health insurance plans delay seeking medical care when they develop their first major symptom of atherosclerotic blood vessel disease, and they experience additional delays in their diagnostic testing and treatment. 
